Researchers at the Stanford University School of Medicine in California found that a decline of PDGF-receptor expression in mice and humans has a similar pattern with a decrease in insulin-producing beta cells. Artificially activating the said molecular pathway might lead to the development of treatments for diabetes, experts reported in Nature.

Full Story:

Related Summaries